Marcadia Biotech Articles
Lilly gets rights to Marcadia's glucagon analogs; Abbott to market Kowa's Livalo in Australia and New Zealand
29 June 2010
Showing 1-1 of 1 articles
- 1
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
